Atos Appoints Philippe Salle
Salle will assume his position as CEO from Feb. 1, 2025, while his appointment as chairman of the board of directors is ...
Atos launches its Experience Operations Center in partnership with Nexthink to empower digital workplace performance ...
A non-binding offer by the French government to buy a key part of Atos’s big data and security business has expired without a ...
IT firm Atos is still aiming to reach a deal with the French state on the sale of its most strategic activities such as ...
Atos and the French government have failed to come to an agreement regarding the acquisition of Atos' assets. The offer, ...
Press Release Atos Group and AWS launch Global GenAI Innovation Studio to accelerate AI-powered business transformation Cutting-edge 6,000sqft facility unlocks the potential of generative AI, enabling ...
Atos SE (OTCMKTS:AEXAY – Get Free Report) saw a large drop in short interest in the month of September. As of September 30th, there was short interest totalling 10,300 shares, a drop of 37.2% from the ...
Atossa Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing innovative medicines in areas of significant unmet medical need in oncology with a focus on using (Z)-endoxifen to ...